Raphael Pharmaceutical (RAPH) Prepaid Assets (2020 - 2025)
Raphael Pharmaceutical's (RAPH) quarterly Prepaid Assets came in at $4000.0 in Q4 2025, down 33.33% year-on-year from $6000.0 in Q4 2024, and up 100.0% quarter-over-quarter from $2000.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Prepaid Assets (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has disclosed Prepaid Assets across 6 years of filings, most recently posting $4000.0 for Q4 2025.
- Prepaid Assets for Q4 2025 came in at $4000.0, down 33.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $4000.0 (down 33.33% YoY), and the FY2025 annual result was $4000.0, down 33.33% from the prior year.
- Prepaid Assets came in at $4000.0 for Q4 2025 at Raphael Pharmaceutical, up from $2000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $269000.0 in Q4 2021 to a low of $2000.0 in Q3 2025.
- The 5-year median for Prepaid Assets is $25500.0 (2021), against an average of $49444.4.
- Across the five-year window, Prepaid Assets surged 296.15% in 2023 and slumped 91.26% in 2024, its largest moves.
- Raphael Pharmaceutical's Prepaid Assets stood at $269000.0 in 2021, then slumped by 84.01% to $43000.0 in 2022, then plunged by 83.72% to $7000.0 in 2023, then fell by 14.29% to $6000.0 in 2024, then plunged by 33.33% to $4000.0 in 2025.
- The last three Prepaid Assets figures came in at $4000.0 (Q4 2025), $2000.0 (Q3 2025), and $8000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Raphael Pharmaceutical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 103,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 111,000.00 |
| Dec 31, 2022 | 43,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 61,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 269,000.00 |
| Sep 30, 2021 | 25,000.00 |
| Dec 31, 2020 | 228,000.00 |